Involvement of p21(Waf1/Cip1) and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate

Carcinogenesis

Volumn 21, Issue 1, 2000, Pages 7-14

  Chai, F ^a   Evdokiou, A ^a   Young, G P ^b   Zalewski, P D ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CASPASE; CASPASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR; HISTONE DEACETYLASE; PROTEIN P21; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 0033963601     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.1.7     Document Type: Article

References (37)

1. Young, G.P. (1996) Screening for colorectal cancer: an introduction. In Young, G.P., Levin, B. and Rozen, P. (eds) Prevention and Early Detection of Colorectal Cancer. WB Saunders, London, UK, pp. 271-274.
2. Cho, K.R. and Vogelstein, B. (1992) Suppressor gene alterations in the colorectal adenoma-carcinoma sequence. J. Cell. Biochem., 16G (suppl.), 137-141.
3. Young, G.P. and Gibson, P.R. (1994) Butyrate and the colorectal cancer cell. In Binder, H.J., Cummings, J.H. and Soergel, K. (eds) Short Chain Fatty Acids. Kluwer, Lancaster, UK, pp. 148-160.
4. Young, G.P. and Gibson, P.R. (1991) Contrasting effects of butyrate on proliferation and differentiation of normal and neoplastic cells. In Rombeau, J.L., Cummings, J.H. and Sakata, T. (eds) Short Chain Fatty Acids: Metabolism and Clinical Importance. Ross Laboratories, Columbus, OH. pp. 50-55.
5. Young, G.P., McIntyre, A., Albert, V. Folino, M., Muir, J.G. and Gibson, P.R. (1996) Wheat bran suppresses potato starch-potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat model. Gastroenterology, 110, 508-514.
6. McIntyre, A., Gibson, P. and Young, G. (1993) Butyrate production from dietary fiber and protection against large bowel cancer in a rat model. Gut, 34, 386-391.
7. Calabresse, C., Venturini, L., Ronco, G., Villa, P., Chomienne, C. and Belpomme, J. (1993) Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line. Biochem. Biophys. Res. Commun., 195, 31-38.
8. Hague, A., Elder, D.J., Hicks, D.J. and Paraskeva, C. (1995) Apoptosis in colorectal tumor cells: induction by the short chain fatty acids butyrate, proprionate and acetate and by the bile salt deoxycholate. Int. J. Cancer, 60, 400-406.
9. Medina, V., Young, G.P., Edmonds, B., James, R., Appleton, S. and Zalewski, P.D. (1997) Induction of caspase-3 protease activity and apoptosis by butyrate and another inhibitor of histone deacetylase: dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res., 57, 3697-3707.
10. Roediger, W.E. (1982) Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology, 83, 424-429.
11. Boffa, L.C., Lupton, J.R., Mariani, MR., Ceppi, M., Newmark, H.L., Scalmati, A. and Lipkin, M. (1992) Modulation of colonic epithelial cell proliferation, histone acetylation and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res., 52, 5906-5912.
12. Kruh, J., Defer, N. and Tichonicky, L. (1991) Butyrate and the molecular biology of the large bowel. In Rhombeau, J.L., Cummings, J.H. and Sakata, T. (eds) Short Chain Fatly Acids: Metabolism and Clinical Importance. Ross Laboratories, Columbus, OH, pp. 45-50.
13. Nakano, K., Mizuno, T., Sowa, Y., Orita, T., Yoshino, T., Okuyama, Y., Fujita, T., Ohtani Fujita, N., Matsukawa, Y., Tokino, T., Yamagishi, H., Oka, T., Nomura, H. and Sakai, T. (1997) Butyrate activates the Wafl/Cip1 gene promoter through Spl sites in a p53-negative human colon cancer cell line. J. Biol. Chem., 272, 22199-22206.
14. Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazebnik, Y.A., Munday, A., Raju, S.M., Smulson, E., Yamin, T.-T., Yu, V.L. and Miller, D.K. (1995) Identification and inhibition of the 1CE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376, 37-43.
15. Alnemri, E.S., Livingston, D.J., Nicholson, D.W., Salvesen, G., Thornberry, N.A., Wong, W.W. and Yuan, J. (1996) Human ICE/CED-3 protease nomenclature. Cell, 87, 171.
16. Orth, K., O'Rourke, K., Salvesen, G.S. and Dixit, V.M. (1996) Molecular ordering of apoptotic mammalian ced-3/1CE-like proteases. J. Biol. Chem., 271, 20977-20980.
17. Nicholson, D.W. and Thornberry, N.A. (1997) Caspases: killer proteases. Trends Biochem. Sci., 22, 299-306.
18. O'Connor, P. (1997) Mammalian G1 and G2 phase checkpoints. In Kastan, M.B. (ed.) Cancer Surveys: Checkpoint Controls and Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, Vol. 29, pp. 151-182.
19. Waga, S. and Stillman, B. (1998) Cyclin-dependent kinase inhibitor p21 modulates the DNA primer-template recognition complex. Mol. Cell. Biol., 18, 4177-4187.
20. Archer, S.Y., Meng, S., Shei, A. and Hodin, R.A. (1998) p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. USA. 95, 6791-6796.
21. Vaziri, C., Stice, L. and Faller, D.V. (1998) Butyrate-induced G1 arrest results from p21 independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ., 9, 465-474.
22. Gartel, A.L., Serfas, M.S., Gartel, M., Goufman, E., Wu, G.S., El-Deiry, W.S. and Tyner, A.L. (1996) p21(WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line. Exp. Cell Res., 227, 171-181.
23. Poluha, W., Poluha, D.K., Chang, B., Crosbie, N.E., Schonhoff, C.M., Kilpatrick, D.L. and Ross, A.H. (1996) The cyclin-dependent kinase inhibitor p21 Waf1 is required for survival of differentiating neuroblastoma cells. Mot. Cell. Biol., 16, 1335-1341.
24. Teare, J.M., Islam, R., Flanagan, R., Gallagher, S., Davies, M.G. and Grabau, C. (1997) Measurement of nucleic acid concentrations using the Dyna Quant and the GeneQuanl. Biotechniques, 22, 1170-1174.
25. Agapova, L.S., Ilyinskaya, G.V., Turovets, N.A., Ivanov, A.V., Chumakov, P.M. and Kopnin, B.P. (1996) Chromosome changes caused by alterations of p53 expression. Mutat. Res., 354, 129-138.
26. Buque-Fagot, C., Lallemand, F., Charollais, R.-H. and Mester, J. (1996) Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fibroblasts by a transcription-dependent mechanism. J. Cell Physiol., 166, 631-636.
27. Hague, A., Manning, A.M., Hanlon, K.A., Huschtscha, L.I., Hart, D. and Paraskeva, C. (1993) Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large bowel cancer. Int. J. Cancer, 55, 498-505.
28. Donato, N. and Perez, M. (1998) Tumour necrosis factor-induced apoptosis stimulates p53 accumulation and p21Waf1 proteolysis in ME-180 cells. J. Biol. Chem., 273, 5067-5072.
29. Kip1 mediates apoptosis in endothelial cells through activation of cdk2: role of a caspase cascade. Mol. Cell, 1, 553-563.
30. Gervais, J.L., Seth, P. and Zhang, H. (1998) Cleavage of CDK inhibitor p2l(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis. J. Biol. Chem., 273, 19207-19212.
31. Zhang, Y., Fujita, N. and Tsuruo, T. (1999) Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene, 18, 1131-1138.
32. Widmann, C., Gibson, S. and Johnson, G.L. (1998) Caspase-dependent cleavage of signalling proteins during apoptosis. J. Biol. Chem., 273, 7141-7147.
33. Blagosklonny, M.V., Wu, G.S., Omura, S. and El-Deiry, W.S. (1996) Proteasome-dependent regulation of p21 WAF1/CIP1 expression. Biochem. Biophys. Res. Commun., 227, 564-569.
34. Waldman, T., Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1996). Uncoupling of S phase and mitosis induced by anti-cancer agents in cells lacking p21. Nature (Lond.), 381, 713-716.
35. Prabhu, N., Blagosklonny, M.V., Zeng, Y.-X., Sheng Wu, G., Waldman, T. and El-Deiry,W.S. (1996) Suppression of cancer cell growth by adenovirus expressing p21Waf1/CIP1 deficient in PCNA interaction. Clin. Cancer Res., 2, 1221-1229.
36. WAF1/CIP1/SDI1 lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells. Oncogene, 16, 705-712.
37. Cayrol, C., Knibiehler, M. and Ducommun, B. (1998) p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene, 16, 311-320.